ISMPP Highlights
ISMPP Releases Official Guidance to Address Authorship Challenges Related to COVID-19 Outbreak
Author responsiveness concerns in the wake of the coronavirus disease (COVID-19) global pandemic has resulted in apprehension and numerous inquiries from ISMPP members over the past several weeks. To address these unprecedented circumstances, ISMPP convened a consensus panel of experts to develop an Official Guidance…
Predatory Publishing Joint Position Statement Now in Multiple Languages
AMWA, EMWA, and ISMPP released their Joint Position Statement on Predatory Publishing in July 2019, published in Current Medical Research & Opinion (CMRO). The organizations are pleased to announce that six months after publication, the Joint Position Statement is available in eight languages…
Celebrating Record Attendance and a Successful 2020 European Meeting of ISMPP
The 2020 European Meeting of ISMPP was a resounding success, with a record-setting 350 attendees – an impressive 17% increase over the 300 attendees seen the past two years! Meeting attendees were taken on a fascinating journey…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
How Article-Level Metrics Can Improve Your Publication Planning
Effective publication planning requires a good understanding of the uptake and impact of individual publications. In the past, our ability to measure this has been limited because publication planners have only had access to journal impact factors and citation counts. With the advent of web-native and article-level metrics…
Advisory Boards: Words of Advice and a 10-point Checklist
Are you considering running an advisory board meeting? Do you want to improve on an advisory board you managed recently – or are you about to start planning your first? Do you have questions such as: How do I plan the meeting? How can I ensure compliance with regulations? Whom should I invite? How can I ensure the meeting meets my objectives?…
What Is Health Literacy in Clinical Research Communications, and Why Is It Important?
Communicating with patients about clinical trials is challenging in today’s increasingly complex world of treatment options. While access to information about clinical trials is more widely available, patients with serious illnesses can be easily overwhelmed before they fully understand their options. This gap between access and understanding…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: Manuscript Submitted Before Author Approvals and Data Checks – Now What?
An industry client working on regional publications submits a manuscript to a journal before all authors have approved the final content and before a full data check has been performed. The authors had reviewed all previous drafts of the manuscript… What Would You Do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals